Next Technology Holding Inc.

NasdaqCM:NXTT Stock Report

Market Cap: US$117.4m

Next Technology Holding Balance Sheet Health

Financial Health criteria checks 6/6

Next Technology Holding has a total shareholder equity of $510.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $551.2M and $40.4M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$159.72m
EquityUS$510.85m
Total liabilitiesUS$40.37m
Total assetsUS$551.22m

Recent financial health updates

Recent updates

Analysis Article • Apr 17

Why Investors Shouldn't Be Surprised By WeTrade Group, Inc.'s (NASDAQ:WETG) 49% Share Price Plunge

Unfortunately for some shareholders, the WeTrade Group, Inc. ( NASDAQ:WETG ) share price has dived 49% in the last...
Seeking Alpha • Oct 19

WeTrade Group to increase presence in the health market

WeTrade Group (NASDAQ:WETG) has announced the development plan of the Company's global public health business sector Y-Health, to expand its presence in the health market. Pursuant to the Plan, Y-Health is dedicated to developing business for biotechnology and healthcare companies worldwide. From Aug. 2022, the Co. has established cooperation with Jiqing Biomedical Technology, Parkway Medical, MobiLab Medical Innovatives, and Zhixun Biotechnology to develop their monkeypox test kits business. In the future, the Co. expects to further improve the cooperation mechanism of its Y-Health business segment and provide supports for the global development of biotechnology and healthcare companies. WETG -7.97% premarket to $1.27.
Seeking Alpha • Aug 23

WeTrade partners with Guyguide to provide monkeypox testing kits for travel packages

WeTrade Group (NASDAQ:WETG) said on Tuesday it had entered into strategic cooperation and partnership with Guyguide Limited, a travel agent in Hong Kong, to exclusively design and provide Monkeypox testing kits and insurance coverage products for traveling packages to US, Canada, Australia and European countries. (WETG) is trading 14.4% higher premarket. Guyguide engages in designing, developing, and selling package tours; air tickets and hotel accommodations, as well as ancillary travel related products and services.
Seeking Alpha • Aug 12

WeTrade stock rises 11% on $50M sales contract for monkeypox test kits

WeTrade Group (NASDAQ:WETG) said it will sell monkeypox virus test kits and antigen tests for $50M to Parkway Medical. Under the agreement, Parkway agreed to buy 5M units of nucleic acid test (RT-LAMP) and 6M units of antigen tests (Colloidal Golden Technique) for a total worth $50M, and Parkway has paid $1M as deposit. "We are excited about the sales of monkeypox virus kits and antigen tests to Parkway Medical after obtaining the exclusive sales channel from Jiqing Biomedical Technology Co. Ltd," said WeTrade CEO  Pijun Liu. WETG +11.19% to $16.00 premarket Aug. 12
Seeking Alpha • Aug 05

WeTrade Group shares surge after iniking monkeypox test kit partnership

WeTrade Group (NASDAQ:WETG) stock touched an all-time high of $50.50 in early Friday trading, more than double its previous close of $18.30, after announcing a partnership with Jiqing Bio to exclusively sell monkypox test kits and antigen tests. At 2:15 PM ET, the stock is up ~15% at $21. The two companies plan to produce and provide exclusive sales channels for monkeypox virust test kits and antigen kits worldwide. The partnership also brings WeTrade (WETG) into the medical industry. WeTrade (WETG) describes itself as a technical service provider of software-as-a-service and cloud intelligent system for micro-businesses with its YCloud for marketing, profit management, payment, and supply chain systems. The company uplisted to Nasdaq in an initial public offering in July.

Financial Position Analysis

Short Term Liabilities: NXTT's short term assets ($551.2M) exceed its short term liabilities ($3.0M).

Long Term Liabilities: NXTT's short term assets ($551.2M) exceed its long term liabilities ($37.3M).

Debt to Equity History and Analysis

Debt Level: NXTT is debt free.

Reducing Debt: NXTT has no debt compared to 5 years ago when its debt to equity ratio was 1.5%.

Debt Coverage: NXTT has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: NXTT has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/06 11:50
End of Day Share Price 2026/05/06 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Next Technology Holding Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.